-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
RSV-IN-5
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2415018-86-7.gif)
| Category | Respiratory syncytial Virus (RSV) |
| CAS | 2415018-86-7 |
| Description | RSV-IN-5 (Compound 4) is a potent dual inhibitor of wild-type and mutant respiratory syncytial virus (RSV) fusion proteins. |
Product Information
| Synonyms | RSV-IN-5|CHEMBL4640616|BDBM50541848|HY-146108|CS-0513916 |
| Molecular Weight | 503.64 |
| Molecular Formula | C28H37N7O2 |
| Canonical SMILES | CC1=CC2=C(C=C1)OCCCCN(C3=CC(=NC4=CC(=NN43)C5CCCCN5C2=O)N6CCC(C6)N)C |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 909 |
| Exact Mass | 503.30087345 |
| Target | RSV |
| XLogP3-AA | 3.4 |
